TBWCX
Price
$22.13
Change
+$0.24 (+1.10%)
Updated
Jun 2 closing price
Net Assets
470.99M
VTMNX
Price
$23.25
Change
+$0.06 (+0.26%)
Updated
Jun 2 closing price
Net Assets
304.26B
Interact to see
Advertisement

TBWCX vs VTMNX

Header iconTBWCX vs VTMNX Comparison
Open Charts TBWCX vs VTMNXBanner chart's image
TBWCX vs VTMNX Comparison Chart in %
View a ticker or compare two or three
VS
TBWCX vs. VTMNX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TBWCX is a Hold and VTMNX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VTMNX has more cash in the bank: 304B vs. TBWCX (471M). VTMNX pays higher dividends than TBWCX: VTMNX (2.61) vs TBWCX (0.33). TBWCX was incepted earlier than VTMNX: TBWCX (11 years) vs VTMNX (25 years). TBWCX (2.62) is less costly to investors than VTMNX (0.03). TBWCX is a more actively managed with annual turnover of: 39.30 vs. VTMNX (4.00). TBWCX has a lower initial minimum investment than VTMNX: TBWCX (5000) vs VTMNX (5000000). VTMNX annual gain was more profitable for investors over the last year : 29.00 vs. TBWCX (11.04). VTMNX return over 5 years is better than : 40.65 vs. TBWCX (9.34).
TBWCXVTMNXTBWCX / VTMNX
Total Expense Ratio1.950.036,500%
Annual Report Gross Expense Ratio2.620.038,733%
Fund Existence11 years25 years-
Gain YTD3.01215.49719%
Front LoadN/AN/A-
Min. Initial Investment500050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets471M304B0%
Annual Yield % from dividends0.332.6113%
Returns for 1 year11.0429.0038%
Returns for 3 years34.8860.0558%
Returns for 5 years9.3440.6523%
Returns for 10 years77.89107.2473%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LIQT1.160.11
+10.07%
LiqTech International
MTUS20.360.80
+4.09%
Metallus
VEON55.300.21
+0.38%
VEON Ltd
RYAAY58.72-0.64
-1.08%
Ryanair Holdings plc
GALT2.42-0.19
-7.28%
Galectin Therapeutics